Patients with small melanoma in situ (MIS) on low-risk body sites that was managed with 5-mm margins had a local recurrence rate of 0.9%, results from a retrospective case series from a single ...
Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma Total mesorectal excision (TME) for rectal cancer may result ...
Please provide your email address to receive an email when new articles are posted on . A higher-than-expected percentage of women with breast cancer who underwent breast-conserving surgery underwent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results